People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Alcon changes: The eye care company has appointed Robert Karsunky senior VP and chief financial officer, effective Nov. 1. Karsunky recently served as chief financial officer of the consumer health division of Novartis, the majority shareholder of Alcon as of Aug. 26 (1"The Gray Sheet" Aug. 30, 2010). He succeeds Richard Croarkin, who will remain on Alcon's executive leadership team until Nov. 30, then return to Nestle